Patent CA-3080401-A1 (CA)
Inventor: KALT JOSEPH
IPC: A61M25/00
Filed: 2018-11-08
Abstract: CA 03080401 2020-04-24 (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization 111111 1 11111111 111111 1 11 11111 1 111 11111 1 11 11111 1111 11111 1111 11111 1 11 11111111111 1 111111 International Bureau (10) International Publication Number (43) International Publication Date WO 2019/094591 Al 16 May 2019 (16.05.2019) WIPO I PCT (51) International Patent Classification: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, A 61M 25/00 (2006.01) A61M 2 7/00 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ED, EL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (21) International Application Number: KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, PCT/U52018/059825 MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (22) International Filing Date: OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, 08 November 2018 (08.11.2018) SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (25) Filing Language: English (84) Designated States (unless otherwise indicated, for every (26) Publication Language: English kind of regional protection available): ARIPO (BW, GH, (30) Priority Data: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, 62/584,006 09 November 201'7 (09.11.201'7) US UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (71) Applicant: TARIS BIOMEDICAL LLC [US/US]; 113 EE, ES, FI, FR, GB, GR, HR, HU, EE, IS, IT, LT, LU, LV, Hartwell Avenue, Lexington, Massachusetts 02421 (US). MC, 1VIK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (72) Inventors: KALT, Joseph; 126 George Street, Arling- TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ton, Massachusetts 024'76 (US). LEE, Heejin; 1103 Albion KM, ML, MR, NE, SN, TD, TG). Road, Bedford, Massachusetts 01'730 (US). Declarations under Rule 4.17: (74) Agent: KING, Kevin W. et al.; EVERSHEDS SUTHER- as to applicant's entitlement to apply for and be granted a LAND (US) LLP, 999 Peachtree Street, NE, Atlanta, Geor-patent (Rule 4.17(ii)) gia 30309-3996 (US). ¨ as to the applicant's entitlement to claim the priority of the (81) Designated States (unless otherwise indicated, for every earlier application (Rule 4.17(iii)) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (54) Title: DRUG DELIVERY DEVICES AND METHODS FOR USE WITH A URINARY CATHETER (57) Abstract: Drug delivery devices (200) and methods of their use are provided. In one 40. embodiment, a drug delivery device (200) for use with a urinary catheter (100) includes a drug 402 102 8 reservoir configured to be disposed outside of a patient's body, and a flexible elongate body 40. 6. 46 124 m ,50 A R (220) attached to the drug reservoir (230) and configured to traverse the patient's urethra to reach the bladder. The drug reservoir (230) includes a drug chamber (234) containing a drug 106 therein, a fluid chamber (236) containing a fluid therein, and an osmotic barrier (238) sepa-rating the drug chamber (234) and the fluid chamber (236). The body includes a drug delivery 141 44L. lumen (222) extending therethrough and in fluid communication with the drug chamber (234). 142-/ i N -134 /-410-, 110 12. 122-- 132 \_p 408-, y-108 -132 138 ,re 104 136 404 126 FIG. 4E 1-1 [Continued on next page] CA 03080401 2020-04-24 WO 2019/094591 A1 I IllIl NMI II lIllIl 0 Ill 1111101111111 I 00111111 11111111111111111011111111111110111111 Published: ¨ with international search report (Art. 21(3)) ¨ before the expiration of the time limit for amending the claims and to be republished in the event of receipt of amendments (Rule 48.2(h))